EUVIMEDEUVIMED entdecken
Open Access

Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis

Rahul D Jana, Hieu D Nguyen iD, Guangjie Yan, Tai-Yen Chen iD, Loi H Do iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c02741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Rahul D Jana und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Houston, 4800 Calhoun Rd., Houston, Texas 77204, United States. Hauptthemen laut MEDLINE: Iridium, Mitochondria, Parkinsonian Disorders, Reactive Oxygen Species. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the application of organoiridium complexes as catalytic agents for the detoxification of biogenic reactive aldehyde species (RASP), which are implicated in the pathogenesis of neurodegenerative disorders. We show that Ir complexes functionalized with phosphonium cations localize selectively in the mitochondria and have better cellular retention compared to that of their parent Ir species. In a cell model for Parkinsonism, the mitochondria-targeted iridium catalysts exhibited superior cell protecting abilities and longer-lasting effects (up to 6 d) than conventional RASP scavengers, which failed to be effective beyond 24 h. Our biological assays indicate that treatment with the Ir compounds led to reduction in reactive oxygen species and aldehyde levels while partially preserving the native mitochondrial membrane potential and NAD+/NADH ratio in 1-methyl-4-phenylpyridinium-inhibited cells. Our work is the first to demonstrate catalytic nonenzymatic detoxification of RASP in living systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridiumMitochondriaParkinsonian DisordersReactive Oxygen SpeciesCatalysisHumansAnimalsAldehydesMembrane Potential, MitochondrialNADCoordination Complexes

Substanzen

IridiumReactive Oxygen SpeciesAldehydesNADCoordination Complexes

Autor:innen und Institutionen

  • Department of Chemistry, University of Houston, 4800 Calhoun Rd., Houston, Texas 77204, United States.

ORCID-Profile: Hieu D Nguyen, Tai-Yen Chen, Loi H Do

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Jana, R. D., Nguyen, H. D., Yan, G., Chen, T. Y., & Do, L. H. (2025). Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02741

Vancouver

Jana RD, Nguyen HD, Yan G, Chen TY, Do LH. Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02741

BibTeX
@article{Jana2025,
  author = {Jana, Rahul D and Nguyen, Hieu D and Yan, Guangjie and Chen, Tai-Yen and Do, Loi H},
  title = {Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c02741}
}
Kostenlos starten →